首页|低分子肝素钠联合地屈孕酮治疗先兆流产患者的效果

低分子肝素钠联合地屈孕酮治疗先兆流产患者的效果

扫码查看
目的:观察低分子肝素钠联合地屈孕酮治疗先兆流产患者的效果.方法:回顾性分析 2019 年 3 月至 2022 年 10 月该院收治的 98 例先兆流产患者的临床资料,按照治疗方法不同将其分为对照组与观察组各 49 例.对照组予以地屈孕酮治疗,观察组在对照组基础上联合低分子肝素钠治疗,两组均连续治疗 1 周.比较两组临床疗效、临床指标(阴道流血停止时间、腹痛消失时间、孕酮恢复时间)水平、治疗前后凝血功能指标[D-二聚体(D-D)、纤维蛋白原(FIB)、血小板计数(PLT)]水平、不良反应发生率和分娩结局.结果:观察组治疗总有效率为95.92%(47/49),高于对照组的83.67%(41/49),差异有统计学意义(P<0.05);观察组阴道流血停止时间、腹痛消失时间、孕酮恢复时间均短于对照组,差异有统计学意义(P<0.05);治疗后,观察组D-D、FIB、PLT水平均低于对照组,差异有统计学意义(P<0.05);观察组足月分娩率为 87.76%(43/49),高于对照组的 65.31%(32/49),差异有统计学意义(P<0.05);两组不良反应发生率、流产率、早产率比较,差异均无统计学意义(P>0.05).结论:低分子肝素钠联合地屈孕酮治疗先兆流产患者可提高治疗总有效率和足月分娩率,改善临床指标水平,降低凝血功能指标水平,效果优于单纯地屈孕酮治疗.
Effects of low molecular weight Heparin sodium combined with Dydrogesterone in treatment of patients with threatened abortion
Objective:To observe effects of low molecular weight Heparin sodium combined with Dydrogesterone in treatment of patients with threatened abortion.Methods:The clinical data of 98 patients with threatened abortion admitted to this hospital from March 2019 to October 2022 were retrospectively analyzed.According to different treatment methods,they were divided into control group and observation group,49 cases in each.The control group was treated with Dydrogesterone,while the observation group was treated with low molecular weight Heparin sodium on the basis of that of the control group.Both groups were treated continuously for 1 week.The clinical efficacy,the clinical indicators(vaginal bleeding stop time,abdominal pain disappearance time,progesterone recovery time)levels,the coagulation function indicators[D-dimer(D-D),fibrinogen(FIB),platelet count(PLT)]levels before and after the treatment,the incidence of adverse reactions,and the birth outcomes were compared between the two groups.Results:The total effective rate of the observation group was 95.92%(47/49),which was higher than 83.67%(41/49)of the control group,and the difference was statistically significant(P<0.05).The vaginal bleeding stop time,the abdominal pain disappearance time and the progesterone recovery time in the observation group were shorter than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of D-D,FIB and PLT in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The full-term delivery rate in the observation group was 87.76%(43/49),which was higher than 65.31%(32/49)in the control group,and the difference was statistically significant(P<0.05).However,there were no significant differences in the incidence of adverse reactions,the abortion rate and the premature delivery rate between the two groups(P>0.05).Conclusions:Low molecular weight Heparin sodium combined with Dydrogesterone in the treatment of the threatened abortion patients can improve the total effective rate of treatment and the full-term delivery rate,improve the levels of clinical indicators,and reduce the levels of coagulation function indicators.Moreover,it is superior to single Dydrogesterone treatment.

Low molecular weight Heparin sodiumDydrogesteroneThreatened abortionCoagulation functionAdverse reactionBirth outcome

吴楠楠

展开 >

郑州圣玛妇产医院药剂科,河南 郑州 450000

低分子肝素钠 地屈孕酮 先兆流产 凝血功能 不良反应 分娩结局

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(2)
  • 9